Robert Schwartz
Internal Medicine · Harrisburg, PANPI 1063501559
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,850 and has fallen 96.7% since, to $62 in 2022.
Across 177 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$294
- Pfizer$246
- Novo Nordisk$240
- Amgen$234
- AbbVie$230
- Lilly USA, LLC$194
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,442100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 15 | $294 |
| Pfizer | 27 | $246 |
| Novo Nordisk | 20 | $240 |
| Amgen | 16 | $234 |
| AbbVie(2 entities) | 13 | $230 |
| Lilly USA, LLC | 15 | $194 |
| Merck | 14 | $148 |
| AstraZeneca | 10 | $141 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $89 |
| GSK | 6 | $78 |
| E.r. Squibb & Sons, L.L.C. | 4 | $77 |
| Sanofi Pasteur Inc. | 5 | $67 |
| Amarin Pharma, Inc. | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Astellas Pharma US Inc | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Mannkind Corporation | 3 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Novartis | 2 | $30 |
| Johnson & Johnson | 2 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $19 |
| IBSA Pharma Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Philips North America LLC | 1 | $13 |
How this compares
$2,449 in reported general payments places this provider in the 85th percentile of 5,705 internal medicine providers in Pennsylvania.
Other internal medicine in Harrisburg
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
- Mohammed KidwaiBala Cynwyd$894K
- Ronak BhimaniNorristown$623K
- David GoldmannPhiladelphia$525K
- Christopher StillDanville$442K
- Jeffrey FreidLower Gwynedd$425K
- Cheryl PegusSpring House$370K
- Eyob FeyssaPhiladelphia$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.